Speaker Profile

Chief Executive Officer, Scipher Medicine

Alif is a pioneer in using network science and artificial intelligence to solve some of the most difficult challenges in healthcare. As the CEO of Scipher Medicine, he is pioneering the development of technologies to match each patient with their most effective therapy. Concerned by the healthcare system’s inability to prescribe the right drugs to the right patients, Alif and his team are developing and commercializing precision diagnostics and therapeutics in autoimmune diseases. With a unique global perspective on healthcare, Alif has led cross-disciplinary teams throughout Asia, Europe, and the Americas and raised more than $350 million in venture and private equity capital to bring novel technologies to market. Through Alif’s leadership, entrepreneurial spirit, and scientific expertise, Scipher will continue to leverage AI and network medicine to continue improving healthcare utilization and patient outcomes.

Genomic Profiling Showcase:
Scipher Medicine

Scipher Medicine is a precision immunology company matching each patient with their most effective therapy.

 Session Abstract – PMWC 2022 Silicon Valley

Track 7, June 28-30

The PMWC 2022 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.